Bioequivalence Study of Bosutinib Pediatric Capsule Relative to Commercial Tablet Under Fed Condition

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 16, 2020

Primary Completion Date

January 15, 2021

Study Completion Date

January 15, 2021

Conditions

Healthy Participants

Interventions

DRUG

Bosutinib capsule

100 mg dose of bosutinib pediatric capsule

DRUG

Bosutinib tablet

100 mg dose of bosutinib tablet

Trial Locations (2)

PRA Health Sciences, Groningen

PRA Health Sciences Utrecht, Utrecht